Functional status and quality of life in light-chain amyloidosis: advanced imaging, longitudinal changes, and outcomes

OF Clerc, S Vijayakumar, SAM Cuddy, G Bianchi… - Heart Failure, 2024 - jacc.org
Background In light-chain (AL) amyloidosis, whether functional status and heart failure–
related quality of life (HF-QOL) correlate with cardiomyopathy severity, improve with therapy …

Systematic literature review of evidence in amyloid light-chain amyloidosis

C Lee, A Lam, T Kangappaden… - Journal of …, 2022 - becarispublishing.com
Introduction: Treatment of amyloid light-chain (AL) amyloidosis, a rare disease with a< 5-
year lifespan, remains challenging. This systematic literature review (SLR) aimed to …

Physical function, psychosocial status, and symptom burden among adults with plasma cell disorders and associations with quality of life

CE Jensen, SN Vohra, KA Nyrop, AM Deal… - The …, 2022 - academic.oup.com
Background The plasma cell disorders (PCDs), multiple myeloma (MM), and light-chain
amyloidosis (AL) are disproportionately diseases of older adults, whose care may be …

Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis

M Gertz, R Abonour, SN Gibbs, M Finkel… - ClinicoEconomics …, 2023 - Taylor & Francis
Purpose Patients with diagnosed with systemic light chain (AL) amyloidosis at advanced
Mayo stages have greater morbidity and mortality than those diagnosed at non-advanced …

Association Between Hematologic Response and Change in Health-Related Quality of Life Among Patients with Light-Chain (AL) Amyloidosis

AA Rizio, KL McCausland, MK Carty… - Patient Related …, 2023 - Taylor & Francis
Purpose The purpose of this secondary data analysis was to examine the association
between hematologic response and health-related quality of life (HRQoL) among patients …